Nohla Therapeutics Overview
- Founded
-
2015
- Status
-
Out of Business
- Employees
-
43
- Latest Deal Type
-
Out of Business
Nohla Therapeutics General Information
Description
Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical diseases. The company's products are based on a unique umbilical cord blood expansion platform, providing doctors the functional support of bone marrow in response to each patient's unique blood-production needs, without any requirement for HLA matching.
Contact Information
Website
www.nohlatherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 1600 Fairview Avenue East
- Suite 100
- Seattle, WA 98102
- United States
+1 (206) 000-0000
Nohla Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-Nov-2019 | 00000 | Completed | Out of Business | ||
| 4. Early Stage VC (Series B) | 12-Jul-2018 | 0000 | 00000 | Completed | Clinical Trials - Phase 2 | |
| 3. Grant | 28-Sep-2017 | 00.00 | 000.00 | Completed | Startup | |
| 2. Early Stage VC (Series A) | 29-Nov-2016 | $43.5M | $64.5M | 00000 | Completed | Startup |
| 1. Corporate | 24-Dec-2015 | $21M | $21M | Completed | Startup |
Nohla Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 000,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 000,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Nohla Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical
Biotechnology
Seattle, WA
43
As of 2018
00000
00000000 00
00000
000000
d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000 000000000
Philadelphia, PA
00
As of 0000
00000
0000
0000-00-00
00000000000
00000
000000
aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
0000 000000000
Rockville, MD
0
As of 0000
000.00
0000000000 0
000.00
Add Comparison
Nohla Therapeutics Competitors (49)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Carisma Therapeutics | Venture Capital-Backed | Philadelphia, PA | 00 | 00000 | 00000000000 | 00000 |
| 000000000 00000000 | Venture Capital-Backed | Rockville, MD | 0 | 000.00 | 0000000000 0 | 000.00 |
| 00 00000000 | Formerly VC-backed | Glasgow, United Kingdom | 00 | 000.00 | 00000000 | 000.00 |
| 000000 | Venture Capital-Backed | Utrecht, Netherlands | 00 | 00.000 | 0000000000 0 | 00.000 |
| 000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
Nohla Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
